Molecular Diagnostics In Pharmacogenomics Market

Future Market Insights

Key Insight

The molecular diagnostics in pharmacogenomics market is projected to grow from USD 748.5 million in 2025 to USD 1,450.5 million by 2035, at a CAGR of 6.8%. Kits and assays will dominate with a 48.1% market share, while oncology will lead the therapeutic area outlook segment with a 33.4% share.

September 22, 2025

Anurag Sharma

250 Pages

Cite this Report

Molecular Diagnostics In Pharmacogenomics Market

https://www.futuremarketinsights.com/reports/molecular-diagnostics-in-pharmacogenomics-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott Molecular
Agilent Technologies
Genomind
Illumina
Invitae Corporation
Myriad Genetics
OneOme
Qiagen
Hoffmann-La Roche
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Molecular Diagnostics In Pharmacogenomics Market

Key Players

Similar Industry Reports